Immunotherapy: Up to Date Progress in Childhood and Hematological Malignancies

  • 2,766

    Total downloads

  • 8,962

    Total views and downloads

Submit your idea

Select the journal/section where you want your idea to be submitted:

Submit your manuscript summarySubmit your manuscript

Articles

CORRECTION

Published on 07 Feb 2024

Corrigendum: Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

  • Águeda Molinos-Quintana
  • Anna Alonso-Saladrigues
  • Blanca Herrero
  • Teresa Caballero-Velázquez
  • Víctor Galán-Gómez
  • Melissa Panesso
  • Montserrat Torrebadell
  • Javier Delgado-Serrano
  • Concepción Pérez de Soto
  • 7 more
  • José Antonio Pérez-Simón
doi 10.3389/fimmu.2024.1373852
  • 610 views

ORIGINAL RESEARCH

Published on 16 Jan 2024

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

  • Águeda Molinos-Quintana
  • Anna Alonso-Saladrigues
  • Blanca Herrero
  • Teresa Caballero-Velázquez
  • Víctor Galán-Gómez
  • Melissa Panesso
  • Montserrat Torrebadell
  • Javier Delgado-Serrano
  • Concepción Pérez de Soto
  • 7 more
  • José Antonio Pérez-Simón
Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
doi 10.3389/fimmu.2023.1280580
  • 3,390 views
  • 4 citations

Participating Journals

Impact

  • 8,962Topic views
  • 5,823Article views
  • 2,766Article downloads
View impact